Browsing Tag
avenanthramides
1 post
From boardroom to executive seat: Puccetti steps in as COSCIENS Biopharma interim chief
COSCIENS Biopharma taps Peter Puccetti as interim CEO to lead cost controls and commercial execution. Find out what this leadership change means for 2026.